Cytek Biosciences Inc (CTKB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Sales | 62,141 | 52,293 | 45,602 | 41,457 | 57,476 |
| Cost of Goods | 29,256 | 24,742 | 21,735 | 21,300 | 23,824 |
| Gross Profit | 32,885 | 27,551 | 23,867 | 20,157 | 33,652 |
| Operating Expenses | 38,734 | 37,485 | 35,226 | 35,432 | 31,490 |
| Operating Income | -5,593 | -9,192 | -10,624 | -14,975 | 2,986 |
| Interest Expense | -725 | 494 | 414 | 291 | -5,933 |
| Other Income | 837 | 1,917 | 4,263 | 4,000 | 1,403 |
| Pre-tax Income | -4,031 | -7,769 | -6,775 | -11,266 | 10,322 |
| Income Tax | 40,045 | -2,291 | -1,192 | 136 | 680 |
| Net Income Continuous | -44,076 | -5,478 | -5,583 | -11,402 | 9,642 |
| Net Income | $-44,076 | $-5,478 | $-5,583 | $-11,402 | $9,642 |
| EPS Basic Total Ops | -0.35 | -0.04 | -0.04 | -0.09 | 0.07 |
| EPS Basic Continuous Ops | -0.35 | -0.04 | -0.04 | -0.09 | 0.07 |
| EPS Diluted Total Ops | -0.35 | -0.04 | -0.04 | -0.09 | 0.07 |
| EPS Diluted Continuous Ops | -0.35 | -0.04 | -0.04 | -0.09 | 0.07 |
| EPS Diluted Before Non-Recurring Items | -0.04 | -0.04 | -0.04 | -0.09 | 0.07 |
| EBITDA(a) | $-2,550 | $-6,132 | $-7,636 | $-12,091 | $5,727 |